<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE cstgschema SYSTEM "CStg.dtd" [
	<!ENTITY commonssf1lymphoma SYSTEM "commons\commonssf1lymphoma.xml">
	<!ENTITY commonssf2lymphoma SYSTEM "commons\commonssf2lymphoma.xml">
	<!ENTITY commonssf3lymphoma SYSTEM "commons\commonssf3lymphoma.xml">
	<!ENTITY commonssf4lymphoma SYSTEM "commons\commonssf4lymphoma.xml">
	<!ENTITY commonssf5lymphoma SYSTEM "commons\commonssf5lymphoma.xml">
	<!ENTITY commonssf6lymphoma SYSTEM "commons\commonssf6lymphoma.xml">
	<!ENTITY commonhistinclusionlymphoma SYSTEM "commons\commonhistinclusionlymphoma.xml">
	<!ENTITY commonstagelymphomatnm7 SYSTEM "commons\commonstagelymphomatnm7.xml">
	<!ENTITY commonstagelymphoma SYSTEM "commons\commonstagelymphoma.xml">
	<!ENTITY commonextralymphomaextensionstage SYSTEM "commons\commonextralymphomaextensionstage.xml">
]>
<!-- Special handling - schema function and code in default schema function -->
<cstgschema csschemaid= "Lymphoma" status= "DRAFT" revised= "06/28/2011" order= "9100">
	<schemahead>
		<title>
			<maintitle>Hodgkin and Non-Hodgkin Lymphomas of All Sites (excluding Mycosis Fungoides and Sezary Disease)</maintitle>
			<subtitle/>
			<sitesummary></sitesummary>
		</title>
		<note>M-9590-9699,9702-9729,9735,9737,9738 (EXCEPT C44.1, C69.0, C69.5-C69.6)</note>
		<note>M-9811-9818,9823,9827,9837 (EXCEPT C42.0, C42.1, C42.4, C44.1, C69.0, C69.5-C69.6) </note>
	</schemahead>

<cstable tableid="aaf" revised="12/30/2009" pattern="1-1-0" type="desc" role="ROLE_TUMOR_SIZE" usage="UNDEFINED" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Tumor Size</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>888</code>
			<descrip><![CDATA[OBSOLETE DATA CONVERTED V0200
See code 988

Not applicable]]></descrip>
		</row>
		<row>
			<code>988</code>
			<descrip><![CDATA[Not applicable: Information not collected for this schema]]></descrip>
		</row>
</cstable>

<cstable tableid="bch" revised="11/11/2010" pattern="1-1-4" type="map4" role="ROLE_EXTENSION" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Extension</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note 1:  An E lesion is defined as disease that involves extralymphatic site(s), or sites other than lymph nodes and other lymphatic structures.  Other lymphatic structures include spleen (see note 4), thymus gland (C37.9), and Waldeyer's ring (tonsils) (C02.4, C09.0-C09.9, C11.1, C14.2),.  Any lymphatic structure (other than spleen) is coded the same as a lymph node region (codes 100, 200, 300).</note>
		<note>Note 2:  While spleen is considered a lymphatic structure, it is coded separately (see codes 120, 220, 230, 320, 330). S equals spleen involvement.</note>
		<note>Note 3:  If there is no mention of lymphatic or extralymphatic involvement but several diagnostic procedures were done, interpret as no involvement.</note>
		<note>Note 4:  Involvement of adjacent soft tissue does not alter the classification.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>TNM 7 Map</coltitle></colhead>
			<colhead><coltitle>TNM 6 Map</coltitle></colhead>
			<colhead><coltitle>SS77 Map</coltitle></colhead>
			<colhead><coltitle>SS2000 Map</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>100</code>
			<descrip><![CDATA[Involvement of a single lymph node region

Stated as Stage I]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>L</code>
			<code>L</code>
		</row>
		<row>
			<code>110</code>
			<descrip><![CDATA[Localized involvement of a single extralymphatic organ/site in the absence of any lymph node involvement
Multifocal involvement of one extralymphatic organ/site

Stated as Stage IE]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>L</code>
			<code>L</code>
		</row>
		<row>
			<code>120</code>
			<descrip><![CDATA[Involvement of spleen only

Stated as Stage IS]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>L</code>
			<code>L</code>
		</row>
		<row>
			<code>200</code>
			<descrip><![CDATA[Involvement of two or more lymph node regions on the SAME side of the diaphragm

Stated as Stage II]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>RNOS</code>
			<code>RNOS</code>
		</row>
		<row>
			<code>210</code>
			<descrip><![CDATA[Localized involvement of a single extralymphatic organ/site
WITH involvement of its regional lymph node(s)
WITH or WITHOUT involvement of other lymph node(s) on the SAME side of the diaphragm

Direct extension to adjacent organs or tissues

Stated as Stage IIE]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>RNOS</code>
			<code>RNOS</code>
		</row>
		<row>
			<code>220</code>
			<descrip><![CDATA[Involvement of spleen
PLUS lymph node(s) BELOW the diaphragm

Stated as Stage IIS]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>RNOS</code>
			<code>RNOS</code>
		</row>
		<row>
			<code>230</code>
			<descrip><![CDATA[Involvement of spleen 
PLUS involvement of a single extralymphatic organ/site BELOW the diaphragm
WITH/WITHOUT involvement of lymph node(s) BELOW the diaphragm

Stated as Stage IIES]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>RNOS</code>
			<code>RNOS</code>
		</row>
		<row>
			<code>300</code>
			<descrip><![CDATA[Involvement of lymph node regions on BOTH sides of the diaphragm

Stated as Stage III]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>310</code>
			<descrip><![CDATA[Involvement of an extralymphatic organ/site 
PLUS involvement of lymph node(s) on the OPPOSITE side of the diaphragm

Stated as Stage IIIE]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>320</code>
			<descrip><![CDATA[Involvement of the spleen 
PLUS lymph node(s) ABOVE the diaphragm

Involvement of spleen 
PLUS lymph nodes on both sides of the diaphragm.

Stated as Stage IIIS]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>330</code>
			<descrip><![CDATA[320 + 310

Involvement of the spleen 
PLUS a single extralymphatic site ABOVE the diaphragm
WITH or WITHOUT involvement of lymph node(s)

Involvement of the spleen 
PLUS involvement of lymph node region(s) ABOVE the diaphragm
PLUS involvement of a single extralymphatic organ/site on either side of the diaphragm

Stated as Stage IIIES]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>800</code>
			<descrip><![CDATA[Diffuse or disseminated (multifocal) involvement of ONE OR MORE extralymphatic organ(s)/site(s)
WITH OR WITHOUT associated lymph node involvement

Multifocal involvement of MORE THAN ONE extralymphatic organ/site

Involvement of isolated extralymphatic organ in absence of involvement of
adjacent lymph nodes, but in conjunction with disease in distant sites

Metastasis/involvement:
    Bone marrow
    Liver
    Nodular involvement of lung(s)

Stated as Stage IV]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>999</code>
			<descrip><![CDATA[Unknown; extension not stated
Primary tumor cannot be assessed
Not documented in patient record]]></descrip>
			<code>^</code>
			<code>*</code>
			<code>U</code>
			<code>U</code>
		</row>
		<footnote>^ AJCC stage group for this schema is derived directly from CS Extension and CS Site-Specific Factor 2, as shown in the AJCC TNM 7 Stage table. The AJCC Stage Groups I-IV are subdivided into A and B based on the presence or absence of symptoms coded in CS Site-Specific Factor 2.</footnote>
		<footnote>* AJCC stage group for this schema is derived directly from CS Extension and CS Site-Specific Factor 2, as shown in the AJCC TNM 6 Stage table. The AJCC Stage Groups I-IV are subdivided into A and B based on the presence or absence of symptoms as coded in CS Site-Specific Factor 2.</footnote>
</cstable>

<cstable tableid="caf" revised="11/02/2010" pattern="1-1-1" type="map1" role="ROLE_TUMOR_SIZE_EXT_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Tumor Size/Ext Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note:  According to AJCC, "The use of the term pathologic staging is reserved for patients who undergo staging laparotomy with an explicit intent to assess the presence of abdominal disease or to define histologic microscopic disease extent in the abdomen. Staging laparotomy and pathological staging have been essentially abandoned as useful procedures." (7th ed., page )  Therefore, Collaborative Staging uses a modified evaluation scheme for lymphomas, and it applies to the CS Tumor Size/Ext-Eval field only.  The other Eval fields are coded as "not applicable" for this schema.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>0</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging:

No staging laparotomy done. No autopsy evidence used]]></descrip>
			<code>c</code>
		</row>
		<row>
			<code>2</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging:

No surgical resection done, but evidence derived from autopsy (tumor was suspected or diagnosed prior to autopsy)]]></descrip>
			<code>p</code>
		</row>
		<row>
			<code>3</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging:

Staging laparotomy done]]></descrip>
			<code>p</code>
		</row>
		<row>
			<code>8</code>
			<descrip><![CDATA[Meets criteria for autopsy (a) staging:

Evidence from autopsy only (tumor was unsuspected or undiagnosed prior to autopsy).]]></descrip>
			<code>a</code>
		</row>
		<row>
			<code>9</code>
			<descrip><![CDATA[Unknown if staging laparotomy done
Not assessed; cannot be assessed
Unknown if assessed
Not documented in patient record]]></descrip>
			<code>c</code>
		</row>
</cstable>

&notapplymphnodes;

<cstable tableid="eaf" revised="11/12/2009" pattern="1-1-1" type="map1" role="ROLE_LYMPH_NODES_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Lymph Nodes Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>9</code>
			<descrip>Not applicable for this site.</descrip>
			<code></code>
		</row>
</cstable>

&notappreglnpos;

&notappreglnexam;

&notappcsmetsatdx;

<cstable tableid="iaa" revised="11/12/2009" pattern="1-1-1" type="map1" role="ROLE_METS_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Mets Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>9</code>
			<descrip>Not applicable for this site.</descrip>
			<code></code>
		</row>
</cstable>

&commonssf1lymphoma;

&commonssf2lymphoma;

&commonssf3lymphoma;

&commonssf4lymphoma;

&commonssf5lymphoma;

&notappssfactor6;

&notappnewssf7;

&notappnewssf8;

&notappnewssf9;

&notappnewssf10;

&notappnewssf11;

&notappnewssf12;

&notappnewssf13;

&notappnewssf14;

&notappnewssf15;

&notappnewssf16;

&notappnewssf17;

&notappnewssf18;

&notappnewssf19;

&notappnewssf20;

&notappnewssf21;

&notappnewssf22;

&notappnewssf23;

&notappnewssf24;

&notappnewssf25;

&commonhistinclusionlymphoma;

&notappsajcchistdrivensites;

&commonstagelymphomatnm7;

&commonstagelymphoma;

&commonsummarystage;

</cstgschema>

